FDA Drug recall D-1699-2012
Man King Capsules, 2800 mg, boxes of 5 packets, OTC, Developed by: American Wanbao Pharmaceutical International Group and Hainan Wanbao Bio…
- FDA Drug
- Class I
- terminated
- Published 2012-10-03
On 2012-10-03 the FDA classified a Class I recall of Man King Capsules, 2800 mg, boxes of 5 packets, OTC, Developed by: American Wanbao Pharmaceutical International Group and Hainan Wanbao Bio… by Www Vitaminbestbuy Com, citing marketed Without an Approved ANDA/NDA: presence of sildenafil.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1699-2012 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2012-02-23 |
| Published | 2012-10-03 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Www Vitaminbestbuy Com |
| Distribution | US |
Product
Man King Capsules, 2800 mg, boxes of 5 packets, OTC, Developed by: American Wanbao Pharmaceutical International Group and Hainan Wanbao Biological Engineering Co., Ltd., 27 Heping Road, Haikou, Henan Province, UPC 9 009900 0032328
Reason
Marketed Without an Approved ANDA/NDA: presence of sildenafil.
Identifiers
| upc | 90099000032328 |
|---|---|
| code_info | All lots. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1699-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.